Bond Pfitzer 1.75% ( US717081FB45 ) in USD
| Issuer | Pfitzer |
| Market price | |
| Country | United States
|
| ISIN code |
US717081FB45 ( in USD )
|
| Interest rate | 1.75% per year ( payment 2 times a year) |
| Maturity | 18/08/2031 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 1 000 000 000 USD |
| Cusip | 717081FB4 |
| Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) |
| Moody's rating | A1 ( Upper medium grade - Investment-grade ) |
| Next Coupon | 18/02/2026 ( In 72 days ) |
| Detailed description |
Pfizer is a multinational pharmaceutical and biotechnology company headquartered in New York City that researches, develops, manufactures, and markets drugs and vaccines globally. This debt instrument, identified by ISIN US717081FB45 and CUSIP 717081FB4, represents a significant bond issuance from Pfizer, a globally renowned pharmaceutical corporation headquartered in the United States, celebrated for its pioneering contributions to healthcare and biomedical research, with the bond itself currently trading at par (100%) in USD, featuring a 1.75% annual interest rate disbursed semi-annually, a total issuance size of $1,000,000,000, a minimum purchase requirement of $2,000, and a maturity date of August 18, 2031, all underpinned by robust investment-grade credit ratings of A+ from Standard & Poor's and A1 from Moody's. |
Français
Italiano
United States